HYLENEX Recombinant
These highlights do not include all the information needed to use HYLENEX recombinant safely and effectively. See full prescribing information for HYLENEX recombinant. HYLENEX recombinant (hyaluronidase human injection) for infiltration use, for interstitial use, for intramuscular use, for intraocular use, for peribulbar use, retrobulbar use, for soft tissue use and for subcutaneous use Initial U.S. Approval: 2005
75f75f29-e369-449d-aa46-179ae02d1fe9
HUMAN PRESCRIPTION DRUG LABEL
Feb 4, 2023
A-S Medication Solutions
DUNS: 830016429
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Hyaluronidase (Human Recombinant)
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
Drug Labeling Information
HOW SUPPLIED SECTION
16 HOW SUPPLIED/STORAGE AND HANDLING
Product: 50090-4534
NDC: 50090-4534-0 1 mL in a VIAL